160 related articles for article (PubMed ID: 17114428)
1. Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.
Mellanby RJ; Koonce CH; Monti A; Phillips JM; Cooke A; Bikoff EK
J Immunol; 2006 Dec; 177(11):7588-98. PubMed ID: 17114428
[TBL] [Abstract][Full Text] [Related]
2. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
3. The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice.
Morgan MA; Muller PS; Mould A; Newland SA; Nichols J; Robertson EJ; Cooke A; Bikoff EK
PLoS One; 2013; 8(2):e56738. PubMed ID: 23418596
[TBL] [Abstract][Full Text] [Related]
4. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
5. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
6. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.
Luo X; Tarbell KV; Yang H; Pothoven K; Bailey SL; Ding R; Steinman RM; Suthanthiran M
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2821-6. PubMed ID: 17307871
[TBL] [Abstract][Full Text] [Related]
8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
9. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.
Tsai S; Serra P; Clemente-Casares X; Yamanouchi J; Thiessen S; Slattery RM; Elliott JF; Santamaria P
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3471-6. PubMed ID: 23401506
[TBL] [Abstract][Full Text] [Related]
12. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
15. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors.
Jang MH; Seth NP; Wucherpfennig KW
J Immunol; 2003 Oct; 171(8):4175-86. PubMed ID: 14530340
[TBL] [Abstract][Full Text] [Related]
17. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
18. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation in the autoimmune diabetes of the NOD mouse.
Unanue ER
Annu Rev Immunol; 2014; 32():579-608. PubMed ID: 24499272
[TBL] [Abstract][Full Text] [Related]
20. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]